During the past decade, Medikal Park Samsun conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medikal Park Samsun" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Medikal Park Samsun" are "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Medikal Park Samsun" in a lesser frequency.

Most popular intervention types in "Medikal Park Samsun" are "Drug" (10 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "Epacadostat" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medikal Park Samsun" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medikal Park Samsun". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Medikal Park Samsun, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medikal Park Samsun, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".